Continue Reading
Full article on Unknown
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
Market Intelligence Analysis
AI-Powered 80% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters
Athira Pharma has changed its name to LeonaBio, Inc. and ticker symbol to LONA, reflecting its recent acquisition of a Phase 3 program in metastatic breast cancer and its commitment to innovation and leadership.
Market Context
Market impact analysis based on neutral sentiment with 80% confidence.
Sentiment
Neutral
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovationBOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it has changed its name to LeonaBio, Inc. The name change aligns with the Compa
AI Breakdown
Summary
Athira Pharma has changed its name to LeonaBio, Inc. and ticker symbol to LONA, reflecting its recent acquisition of a Phase 3 program in metastatic breast cancer and its commitment to innovation and leadership.
Market Context
Market impact analysis based on neutral sentiment with 80% confidence.
Time Horizon
Short Term
Original article published by
Unknown
on January 9, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.